$NWBO
NORTHWEST BIOTHERAPEUTICS INC

2017 Q2 Form 10-Q Financial Statement

#000114420417044412 Filed on August 21, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $88.00K $157.0K
YoY Change -43.95% -59.85%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.290M $6.470M
YoY Change -18.24% -34.05%
% of Gross Profit
Research & Development $5.466M $8.713M
YoY Change -37.27% -68.66%
% of Gross Profit
Depreciation & Amortization $44.00K $67.00K
YoY Change -34.33% 458.33%
% of Gross Profit
Operating Expenses $5.466M $8.713M
YoY Change -37.27% -68.66%
Operating Profit -$10.67M -$15.02M
YoY Change -29.01% -61.33%
Interest Expense $1.308M $729.0K
YoY Change 79.42% -55.44%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$10.25M -$14.18M
YoY Change -27.72% -78.79%
Income Tax
% Of Pretax Income
Net Earnings -$10.25M -$14.18M
YoY Change -27.67% -78.79%
Net Earnings / Revenue -11651.14% -9028.66%
Basic Earnings Per Share
Diluted Earnings Per Share -$49.17K -$136.6K
COMMON SHARES
Basic Shares Outstanding 191.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.00K $2.140M
YoY Change -99.07% -88.85%
Cash & Equivalents $22.00K $2.140M
Short-Term Investments
Other Short-Term Assets $800.0K $2.350M
YoY Change -65.96% 17.5%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $820.0K $4.500M
YoY Change -81.78% -78.77%
LONG-TERM ASSETS
Property, Plant & Equipment $46.45M $46.89M
YoY Change -0.94% 11.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $120.0K $220.0K
YoY Change -45.45% -79.05%
Total Long-Term Assets $46.56M $47.11M
YoY Change -1.16% 9.44%
TOTAL ASSETS
Total Short-Term Assets $820.0K $4.500M
Total Long-Term Assets $46.56M $47.11M
Total Assets $47.38M $51.61M
YoY Change -8.2% -19.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $37.52M $19.89M
YoY Change 88.64% 79.64%
Accrued Expenses $1.340M
YoY Change 12.79%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $930.0K
YoY Change -100.0% 0.0%
Long-Term Debt Due $17.44M $10.52M
YoY Change 65.78% 4283.33%
Total Short-Term Liabilities $72.79M $59.90M
YoY Change 21.52% -48.6%
LONG-TERM LIABILITIES
Long-Term Debt $9.840M $10.68M
YoY Change -7.87% -54.97%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $9.840M $10.68M
YoY Change -7.87% -55.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $72.79M $59.90M
Total Long-Term Liabilities $9.840M $10.68M
Total Liabilities $82.63M $70.58M
YoY Change 17.07% -49.74%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$35.24M -$18.97M
YoY Change
Total Liabilities & Shareholders Equity $47.38M $51.61M
YoY Change -8.2% -19.67%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$10.25M -$14.18M
YoY Change -27.67% -78.79%
Depreciation, Depletion And Amortization $44.00K $67.00K
YoY Change -34.33% 458.33%
Cash From Operating Activities -$3.700M -$14.20M
YoY Change -73.94% -47.6%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K -$1.620M
YoY Change -99.38% 82.02%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$10.00K -$1.620M
YoY Change -99.38% 82.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $360.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.850M 3.900M
YoY Change -1.28% -90.97%
NET CHANGE
Cash From Operating Activities -3.700M -14.20M
Cash From Investing Activities -10.00K -1.620M
Cash From Financing Activities 3.850M 3.900M
Net Change In Cash 140.0K -11.92M
YoY Change -101.17% -178.37%
FREE CASH FLOW
Cash From Operating Activities -$3.700M -$14.20M
Capital Expenditures -$10.00K -$1.620M
Free Cash Flow -$3.690M -$12.58M
YoY Change -70.67% -52.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
3000000 USD
CY2016Q2 us-gaap Revenue From Grants
RevenueFromGrants
157000 USD
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
157000 USD
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8713000 USD
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1926000 USD
CY2016Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
15180000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-15023000 USD
CY2016Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3930000 USD
CY2016Q2 us-gaap Interest Expense
InterestExpense
729000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-14175000 USD
CY2016Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-2353000 USD
CY2017Q2 us-gaap Revenue From Grants
RevenueFromGrants
88000 USD
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3284000 USD
CY2017Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
10753000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-10665000 USD
CY2017Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
6457000 USD
CY2017Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
2270000 USD
CY2016Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2017Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
46564000 USD
CY2016Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
45022000 USD
CY2016Q4 us-gaap Assets
Assets
52906000 USD
CY2017Q2 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
6200000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
76405000 USD
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
72790000 USD
CY2017Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
46221000 USD
CY2016Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
44559000 USD
CY2017Q2 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
4749000 USD
CY2016Q4 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
5200000 USD
CY2017Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
2170000 USD
CY2016Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
310000 USD
CY2017Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 USD
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
103831000 shares
us-gaap Sales Revenue Net
SalesRevenueNet
393000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22153000 USD
us-gaap Interest Expense
InterestExpense
1447000 USD
us-gaap Net Income Loss
NetIncomeLoss
-20281000 USD
CY2017Q2 us-gaap Debt Default Longterm Debt Amount
DebtDefaultLongtermDebtAmount
4749000 USD
CY2017Q2 us-gaap Legal Fees
LegalFees
2003000 USD
CY2016Q2 us-gaap Legal Fees
LegalFees
4541000 USD
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
208458000 shares
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5261000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
32895000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
156000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10501000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-22569000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
7896000 USD
us-gaap Interest Expense
InterestExpense
2502000 USD
us-gaap Net Income Loss
NetIncomeLoss
-22873000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-8542000 USD
us-gaap Legal Fees
LegalFees
5935000 USD
us-gaap Legal Fees
LegalFees
5481000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
185108000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
100782000 shares
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13638000 USD
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11579000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-1037000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
1640000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
693000 USD
nwbo Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
100000 USD
nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
1847000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1640000 USD
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1389000 USD
nwbo Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-212000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-31801000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-15976000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-4303000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
211000 USD
nwbo Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-337000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
80000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000 USD
nwbo Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
-29000 USD
nwbo Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
-49000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
11899000 USD
nwbo Proceeds From Issuance Of Capital Stock And Warrants
ProceedsFromIssuanceOfCapitalStockAndWarrants
7760000 USD
nwbo Proceeds From Issuance Of Capital Stock And Warrants
ProceedsFromIssuanceOfCapitalStockAndWarrants
10000000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
13138000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2983000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
3021000 USD
CY2016Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
9791000 USD
CY2017Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
5383000 USD
CY2016Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
405000 USD
us-gaap Depreciation
Depreciation
100000 USD
us-gaap Depreciation
Depreciation
80000 USD
CY2017Q2 us-gaap Interest Expense Other
InterestExpenseOther
3000 USD
CY2016Q2 us-gaap Interest Expense Other
InterestExpenseOther
0 USD
CY2017Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1308000 USD
CY2016Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
729000 USD
us-gaap Interest Expense Other
InterestExpenseOther
5000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
693000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
756000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
687000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
431000 USD
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
1704000 USD
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-14655000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3973000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
2740000 USD
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
0 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
880000 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
nwbo Cash Cash Equivalents And Shortterm Investmentsperiod Increase Decrease
CashCashEquivalentsAndShorttermInvestmentsperiodIncreaseDecrease
-6849000 USD
nwbo Cash Cash Equivalents And Shortterm Investmentsperiod Increase Decrease
CashCashEquivalentsAndShorttermInvestmentsperiodIncreaseDecrease
-19945000 USD
CY2016Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
6871000 USD
CY2015Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
23048000 USD
CY2017Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
22000 USD
CY2016Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
3103000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
3258000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
nwbo Stock And Warrants Issued To Related Party Expenses
StockAndWarrantsIssuedToRelatedPartyExpenses
0 USD
nwbo Stock And Warrants Issued To Related Party Expenses
StockAndWarrantsIssuedToRelatedPartyExpenses
2277000 USD
CY2017Q2 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
6200000 USD
us-gaap Site Contingency Loss Exposure In Excess Of Accrual Best Estimate
SiteContingencyLossExposureInExcessOfAccrualBestEstimate
6200000 USD
CY2017Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
6878000 USD
CY2017Q2 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
13702000 USD
CY2016Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4862000 USD
CY2016Q4 us-gaap Debt Default Longterm Debt Amount
DebtDefaultLongtermDebtAmount
5200000 USD
CY2016Q4 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
10062000 USD
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
10062000 USD
CY2017Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
13702000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales
1847000 USD
us-gaap Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-7896000 USD
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
505000 USD
us-gaap Interest Expense Other
InterestExpenseOther
1000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
2502000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
1447000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
47760000 shares
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
58278000 shares
nwbo Number Of Warrants Warrants Exercised For Cash
NumberOfWarrantsWarrantsExercisedForCash
10800000 shares
CY2016Q4 nwbo Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
1.78
nwbo Weighted Average Exercise Price Exercised For Cash
WeightedAverageExercisePriceExercisedForCash
0.02
CY2017Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3495000 USD
CY2016Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
10960000 USD
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Notes Payable Current
NotesPayableCurrent
5661000 USD
CY2016Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2450000 USD
CY2017Q2 us-gaap Secured Debt Current
SecuredDebtCurrent
6115000 USD
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
40000000 shares
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
40000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
237322805 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
237322805 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
157028270 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
157028270 shares
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q2 nwbo Deemed Dividend Related To Warrant Modification
DeemedDividendRelatedToWarrantModification
0 USD
CY2016Q2 nwbo Deemed Dividend Related To Warrant Modification
DeemedDividendRelatedToWarrantModification
2640000 USD
nwbo Deemed Dividend Related To Warrant Modification
DeemedDividendRelatedToWarrantModification
0 USD
nwbo Deemed Dividend Related To Warrant Modification
DeemedDividendRelatedToWarrantModification
2640000 USD
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10253000 USD
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16815000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22873000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22921000 USD
nwbo Stock And Warrants Issued During Period Value Private Placement Net Of Offering Costs
StockAndWarrantsIssuedDuringPeriodValuePrivatePlacementNetOfOfferingCosts
232000 USD
nwbo Tax Receivable Related To Uk Facility
TaxReceivableRelatedToUkFacility
0 USD
nwbo Tax Receivable Related To Uk Facility
TaxReceivableRelatedToUkFacility
408000 USD
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 USD
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
301000 USD
nwbo Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest
IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterest
5462000 USD
nwbo Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest
IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterest
0 USD
nwbo Reclassification Of Warrant Liabilities Related To Cashless Warrants Exercise
ReclassificationOfWarrantLiabilitiesRelatedToCashlessWarrantsExercise
1847000 USD
nwbo Reclassification Of Warrant Liabilities Related To Cashless Warrants Exercise
ReclassificationOfWarrantLiabilitiesRelatedToCashlessWarrantsExercise
0 USD
nwbo Class Of Warrant Or Right Granted Weighted Average Exercise Price
ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice
0.48
CY2016 nwbo Class Of Warrant Or Right Oustanding Remaining Contractual Term
ClassOfWarrantOrRightOustandingRemainingContractualTerm
P3Y10M10D
nwbo Class Of Warrant Or Right Oustanding Remaining Contractual Term
ClassOfWarrantOrRightOustandingRemainingContractualTerm
P3Y1M6D
CY2017Q2 nwbo Current Assets Less Payables
CurrentAssetsLessPayables
72000000 USD
CY2017Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
21400000 USD
CY2017Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
7500000 USD
CY2017Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
18800000 shares
CY2017Q2 nwbo Property Plant And Equipment Net Including Construction In Progress
PropertyPlantAndEquipmentNetIncludingConstructionInProgress
46445000 USD
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
13239000 USD
CY2016Q4 nwbo Property Plant And Equipment Net Including Construction In Progress
PropertyPlantAndEquipmentNetIncludingConstructionInProgress
44874000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><b>Use of Estimates</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 52.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><i>&#160;</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">In preparing condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates. On an ongoing basis, the Company evaluates its estimates and assumptions. These estimates and assumptions include valuing equity securities in share-based payment arrangements, valuing environmental liabilities, estimating the fair value of financial instruments recorded as derivative liabilities, and estimating the useful lives of depreciable assets and whether impairment charges may apply.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q2 nwbo Accounts Payable And Accrued Liabilities Related Parties Current
AccountsPayableAndAccruedLiabilitiesRelatedPartiesCurrent
21373000 USD
CY2016Q4 nwbo Accounts Payable And Accrued Liabilities Related Parties Current
AccountsPayableAndAccruedLiabilitiesRelatedPartiesCurrent
23393000 USD
CY2017Q2 us-gaap Secured Long Term Debt
SecuredLongTermDebt
4453000 USD
CY2017Q1 nwbo Shares Issued During Period Shares Upon Exercise Of Warrants
SharesIssuedDuringPeriodSharesUponExerciseOfWarrants
3100000 shares
CY2017Q1 us-gaap Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
713000 USD
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
729000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
720000 USD
CY2017Q2 us-gaap Notes Payable
NotesPayable
135000 USD
CY2017Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
16149000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
9.90
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.32
CY2016Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
0 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
451000 USD
nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
6266000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
373000 USD
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
3750000 USD
nwbo Stock Issued During Period Value Extinguishment Of Senior Convertible Notes
StockIssuedDuringPeriodValueExtinguishmentOfSeniorConvertibleNotes
2054000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
348000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
373000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
12000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
553000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
nwbo Payment Of Warrants Excercise Offering Cost
PaymentOfWarrantsExcerciseOfferingCost
0 USD
nwbo Payment Of Warrants Excercise Offering Cost
PaymentOfWarrantsExcerciseOfferingCost
341000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1604000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
451000 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
us-gaap Notes Assumed1
NotesAssumed1
5175000 USD
us-gaap Notes Assumed1
NotesAssumed1
0 USD
us-gaap Notes Reduction
NotesReduction
3750000 USD
us-gaap Notes Reduction
NotesReduction
0 USD
us-gaap Notes Issued1
NotesIssued1
1826000 USD
us-gaap Notes Issued1
NotesIssued1
0 USD
nwbo Issuance Of Warrants In Conjunction With Note Payable
IssuanceOfWarrantsInConjunctionWithNotePayable
83000 USD
nwbo Issuance Of Warrants In Conjunction With Note Payable
IssuanceOfWarrantsInConjunctionWithNotePayable
0 USD
nwbo Trade Liabilities Waived By Related Partiesamount
TradeLiabilitiesWaivedByRelatedPartiesamount
3750000 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1551 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
11343 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
238 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12656 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
6546 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.56
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.25
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.63
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y7M6D
nwbo Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y6M
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.25
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y9M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.96 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.02 pure
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.25
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.5 pure
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
50% will vest over a 24-month period in equal monthly installments, provided that the recipient continues to be employed by the Company. The unvested portions of the Options are subject to accelerated vesting upon (i) a change of effective control of the Company, (ii) the filing of the first Biologics License Application or other application for product approval in any jurisdiction, (iii) completion of any randomized clinical trial that meets its endpoint(s) (Phase II or Phase III), (iv) decision by the Board, in its discretion or (v) the death of the recipient.
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
700000 USD
CY2017Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
300000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2017Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
2075000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
4262000 USD
nwbo Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements Related To Conversion Of Sharesettled Debt
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlementsRelatedToConversionOfSharesettledDebt
451000 USD
nwbo Proceeds From Issuance Of Common Stock And Debt
ProceedsFromIssuanceOfCommonStockAndDebt
16000000 USD
us-gaap Debt Instrument Increase Decrease For Period Net
DebtInstrumentIncreaseDecreaseForPeriodNet
5000000 USD
CY2017Q3 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
446000 USD
CY2017Q2 us-gaap Loss Contingency Damages Sought
LossContingencyDamagesSought
The complaint asserts claims for breach of contract and unjust enrichment, and purports to seek at least $1 million, interest, and attorneys fees and costs.
CY2017Q2 nwbo Trade Liabilities Waived By Related Partiesamount
TradeLiabilitiesWaivedByRelatedPartiesamount
3750000 USD
CY2017Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1384615 shares
CY2017Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.26
CY2017Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
360000 USD
CY2017Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3610452 shares
CY2017Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.15
CY2017Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
3274553 shares
CY2017Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.33
CY2017Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
552000 USD
CY2017Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2000000 USD
CY2017Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
11137345 shares
CY2017Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.18
CY2017Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1800000 USD
CY2017Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
900000 USD
CY2017Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
3900000 USD
CY2017Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1600000 USD
CY2017Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
500000 USD
CY2017Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
3300000 shares
CY2017Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.14
CY2017Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
600000 USD
CY2017Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
300000 USD
CY2017Q2 nwbo Class Of Warrants Or Rights Number Of Ratchet Warrants
ClassOfWarrantsOrRightsNumberOfRatchetWarrants
1000000 shares
CY2017Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-700000 USD
CY2017Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-400000 USD
CY2017Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
32664000 USD
CY2017Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
3063000 USD
CY2017Q2 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
348000 USD
CY2017Q2 nwbo Fair Value Of Embedded Conversion Option
FairValueOfEmbeddedConversionOption
2077000 USD
CY2017Q2 us-gaap Long Term Debt
LongTermDebt
32026000 USD
CY2016Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
32561000 USD
CY2016Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
850000 USD
CY2017Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
31000 USD
CY2017Q2 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
128000 USD
CY2017Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
0.01 shares
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
3222000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
628000 USD
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
1730000 USD
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
2121000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
9000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
4303000 USD
nwbo Refund Of Leashold Improvement Related To Uk Construction
RefundOfLeasholdImprovementRelatedToUkConstruction
220000 USD
nwbo Refund Of Leashold Improvement Related To Uk Construction
RefundOfLeasholdImprovementRelatedToUkConstruction
0 USD
nwbo Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Warrant Granted
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisWarrantGranted
9572000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
192778000 shares
nwbo Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
96530000 shares
nwbo Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
22319000 shares
CY2017Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
121689000 shares
nwbo Class Of Warrant Or Right Expired Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice
1.24
CY2017Q2 nwbo Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.98
CY2016Q4 us-gaap Notes Payable
NotesPayable
135000 USD

Files In Submission

Name View Source Status
0001144204-17-044412-index-headers.html Edgar Link pending
0001144204-17-044412-index.html Edgar Link pending
0001144204-17-044412.txt Edgar Link pending
0001144204-17-044412-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nwbo-20170630.xml Edgar Link completed
nwbo-20170630.xsd Edgar Link pending
nwbo-20170630_cal.xml Edgar Link unprocessable
nwbo-20170630_def.xml Edgar Link unprocessable
nwbo-20170630_lab.xml Edgar Link unprocessable
nwbo-20170630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v473640_10q.htm Edgar Link pending
v473640_ex10-1.htm Edgar Link pending
v473640_ex31-1.htm Edgar Link pending
v473640_ex32-1.htm Edgar Link pending